Article

Tyrer-Cuzick Lifetime Risk is Not Associated with Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma

2024-07-01

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose: </bold>The Tyrer-Cuzick lifetime risk score (TC LR) is used to estimate the probability of an unaffected female patient developing breast cancer as well as their likelihood of carrying a <italic>BRCA1/BRCA2 </italic>pathogenic variant (PV), considering factors such as family history, personal history, and breast density. The purpose of this study is to determine if TC LR...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2bfd5089-31e0-5b4b-8e07-08db71ea409d
DOI: 10.21203/rs.3.rs-4547604/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tyrer-Cuzick Lifetime Risk is Not Associated with Non-BRCA1/2 Pathogenic Variants for Breast CarcinomaDOI 10.21203/rs.3.rs-4547604/v1Read

Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma.Semantic proximity Read

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model.Semantic proximity Read

Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial.Semantic proximity Read

Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study.Semantic proximity Read

Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United StatesSemantic proximity Read

Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes.Semantic proximity Read

Rates of high-risk screening prior to a breast cancer diagnosis in patients under age 40.Semantic proximity Read

Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2.Semantic proximity Read

Second Primary Cancer Risks After Breast Cancer in BRCA1 and BRCA2 Pathogenic Variant Carriers.Semantic proximity Read

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis.Semantic proximity Read

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.Semantic proximity Read

Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.Semantic proximity Read